David Jayabalan

The Adipocyte as an Important Target Cell for Trypanosoma cruzi Infection

Terry P. Combs, Nagajyothi, Shankar Mukherjee et al. · Journal of Biological Chemistry · 2005 · 202 citations · Full text

Trypanosoma Cruzi Infection, Pathology, Disease Physiology +18

BiRD (Biaxin [clarithromycin]/Revlimid [lenalidomide]/dexamethasone) combination therapy results in high complete- and overall-response rates in treatment-naive symptomatic multiple myeloma.

Rubén Niesvizky, David Jayabalan, Paul J. Christos et al. · Blood · 2007 · 182 citations · Full text

Stem Cell Mobilization with Cyclophosphamide Overcomes the Suppressive Effect of Lenalidomide Therapy on Stem Cell Collection in Multiple Myeloma

Tomer M. Mark, Jessica Stern, Jessica Furst et al. · Biology of Blood and Marrow Transplantation · 2008 · 115 citations · Full text

Prolonged early G1 arrest by selective CDK4/CDK6 inhibition sensitizes myeloma cells to cytotoxic killing through cell cycle–coupled loss of IRF4

Xiangao Huang, Maurizio Di Liberto, David Jayabalan et al. · Blood · 2012 · 110 citations · Full text

Lenalidomide‐induced myelosuppression is associated with renal dysfunction: adverse events evaluation of treatment‐naïve patients undergoing front‐line lenalidomide and dexamethasone therapy

Rubén Niesvizky, Tara Naib, Paul J. Christos et al. · British Journal of Haematology · 2007 · 89 citations · Full text